← Back to Search

Opioid Destruction Education for Postoperative Care

N/A
Waitlist Available
Led By Kristin R Daniel, PharmD
Research Sponsored by University of Nebraska
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up six to eight weeks post discharge
Awards & highlights
No Placebo-Only Group

Summary

This trial studies how patients use opioid destruction bags after surgery for hip or knee replacement. Patients must be 19+ and prescribed an opioid at discharge. Two groups: one gets standard care, one gets special handout and education on safe storage. 6-8 weeks post-surgery, patients are contacted via phone or email for survey.

Who is the study for?
This trial is for adults who've had a total knee or hip replacement, are going home with an opioid prescription, and haven't used opioids before the surgery. It's not for those under 19 or anyone not prescribed opioids after discharge.
What is being tested?
The study focuses on teaching patients about proper storage and destruction of opioid medications post-surgery. Participants will be followed up within 6-8 weeks to discuss their use, storage, and disposal of these pain meds.
What are the potential side effects?
Since this trial involves education rather than medication administration, there are no direct side effects from interventions being studied.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~six to eight weeks post discharge
This trial's timeline: 3 weeks for screening, Varies for treatment, and six to eight weeks post discharge for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Opioid destruction
Secondary study objectives
Alternative opioid destruction methods

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: InterventionExperimental Treatment1 Intervention
Intervention group will receive a specialized handout and patient education on the safe storage of opioid medications, importance of opioid destruction, opioid destruction options and medication destruction (Deterra) bag before discharge. Surveys will be sent to group at 6-8 weeks post discharge.
Group II: ControlActive Control1 Intervention
Control group will receive current standard of care education and surveys at 6-8 weeks post discharge.

Find a Location

Who is running the clinical trial?

University of NebraskaLead Sponsor
555 Previous Clinical Trials
1,145,084 Total Patients Enrolled
Kristin R Daniel, PharmDPrincipal InvestigatorUniversity of Nebraska

Media Library

Intervention Clinical Trial Eligibility Overview. Trial Name: NCT05875857 — N/A
Opioid Use Disorder Research Study Groups: Control, Intervention
Opioid Use Disorder Clinical Trial 2023: Intervention Highlights & Side Effects. Trial Name: NCT05875857 — N/A
Intervention 2023 Treatment Timeline for Medical Study. Trial Name: NCT05875857 — N/A
~0 spots leftby Dec 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top